BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,745,352 | +43.9% | 751,600 | +81.1% | 1.52% | +65.9% |
| Q2 2023 | $26,228,000 | +41.0% | 415,000 | +42.5% | 0.92% | +136.7% |
| Q1 2022 | $18,601,000 | -82.5% | 291,184 | -70.7% | 0.39% | -82.9% |
| Q4 2021 | $106,574,000 | +24.6% | 995,000 | +19.6% | 2.26% | +19.3% |
| Q3 2021 | $85,538,000 | +72.7% | 832,000 | +47.7% | 1.90% | +41.5% |
| Q2 2021 | $49,539,000 | -6.7% | 563,200 | +3.2% | 1.34% | -8.7% |
| Q1 2021 | $53,088,000 | +97.2% | 546,000 | +127.5% | 1.47% | +67.8% |
| Q4 2020 | $26,916,000 | – | 240,000 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |